Skip to main content
BMC Oral Health logoLink to BMC Oral Health
. 2022 Dec 15;22:609. doi: 10.1186/s12903-022-02661-w

Increased dental visits in patients with rheumatoid arthritis: a secondary cohort analysis of population based claims data

Ching-Ya Juan 1, Chia-Wen Hsu 2, Ming-Chi Lu 3,4,
PMCID: PMC9753417  PMID: 36522732

Abstract

Objective

To study the utilization of dental care in patients with rheumatoid arthritis (RA) and compare the incidence of common dental disorders in patients with and without RA.

Methods

This data used in this study was from the population-based Taiwan's National Health Insurance Research Database. We identified 1337 patients with newly diagnosed RA between January 2000 and December 2012. We also identified 13,370 individual without a diagnosis of RA using frequency matching on 5-year age intervals, sex, and index year. Patients with a diagnosis of primary Sjögren's syndrome were excluded. Dental disorders were identified using respective ICD-9-CM codes confirmed by dentists. The incidence and incidence rate ratio [IRR] of each dental disorders were calculated using Poisson regression.

Results

Compared with the comparison cohort, the prevalence of dentist visits in the RA cohort were significantly higher (70.3% vs. 66.7%, p = 0.008) and the frequency of dentist visits in the RA cohort were also significantly higher (median 2.67 vs. 1.78 per year, p < 0.001). In addition, the incidence of visits for dental caries (adjusted IRR 1.16, p < 0.001), pulpitis (adjusted IRR 1.12, p = 0.044), gingivitis (adjusted IRR 1.13, p = 0.027), periodontitis (adjusted IRR 1.13, p = 0.004), and oral ulcer (adjusted IRR 1.24, p = 0.003) were higher in patients with RA.

Conclusions

An elevated prevalence and frequency of dental visits were associated with patients with RA. In addition, elevated incidence of dental disorders, including dental caries, pulpitis, gingivitis, periodontitis, and oral ulceration, were observed. Oral health should be accessed regularly in patients with RA.

Keywords: Rheumatoid arthritis, Dental disorders, Dental caries, Pulpitis, Gingivitis, Periodontitis, Oral ulcer

Introduction

Systemic diseases can affect oral health and studies have shown that many systemic diseases, including rheumatoid arthritis (RA) are closely associated with dental disorder [1]. RA is a common systemic autoimmune disease characterized by persistent joint inflammation leading to increased mortality. The prevalence of RA was estimated to be between 0.5 and 1.0% with a female to male ratio of approximately 2.5:1 [2]. In Taiwan, the prevalence of RA was reported to be 0.26–0.93% [3]. RA can affect not only the joints, but it can also involve other organ systems, such as the lung, skin vasculitis, and lead to systemic comorbidities [4, 5]. Among these comorbidities or extra-articular manifestations, dental disorders are common in patients with RA, which would increase the need of treatment from dental professionals [6].

Among dental disorders, it is well known that patients with periodontitis have an increased risk of developing RA, and that patients with RA also showed an increased risk of developing periodontitis [7, 8]. Martinez-Martinez et al. reported that the frequency and severity of dental caries were higher in patients with RA compared with controls [9]. In addition, the prevalence of temporomandibular disorders was found to be higher in patients with RA [10, 11]. However, the prevalence and incidence of common dental disorders, such as dental caries, pulpitis, oral ulcer, and stomatitis in patients with RA, was not clear. We hypothesized that the incidence of common dental disorders is higher in patients with RA. In this study, we compared the prevalence of dental conditions and the frequency of dental visits in patients with or without RA. We also performed separate analyses to assess the incidence and incidence rate ratios (IRRs) of common dental disorders.

Materials and methods

Identification of the RA cohort and a comparison cohort

This is a secondary cohort analysis based on the claim data from Taiwan's National Health Insurance Research Database (NHIRD). The study design was based on our previous study with modifications [12]. The study protocol was reviewed and approved by the institutional review board of Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Taiwan (No.B10004021). The need for informed consent from individuals was waived because the data in NHIRD were deidentified.

Patients with newly diagnosed RA were identified based on the International Classification of Diseases, Ninth revision, clinical modification (ICD-9-CM) code 714.0 (rheumatoid arthritis) using the 2000–2012 catastrophic illness datafile of the NHIRD. RA is considered a catastrophic illness in Taiwan. Patients with RA can apply for a certificate from the National Health Insurance Administration (NHIA), and their medical records, serological, pathological, and imaging reports will be reviewed by at least two specialists. If approved, holders of a RA catastrophic illness certificate are exempted from copayments for health care expenses related to the treatment of RA. The diagnosed of RA was based on the American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis [13]. The date of application for the catastrophic illness certificate was defined as the index date for RA in this study. Patients whose ages less than 20 years, more than 80 years on the index date or with a diagnosis of primary Sjögren’s syndrome, defined by the catastrophic illness datafile, were excluded from the study. The ending year of the dataset was 2012 because of a change in data protection policy in Taiwan.

A comparison cohort was constructed based on a random sample of the outpatient datafile of the 2000 Longitudinal Health Insurance Database (LHID 2000) of the NHIRD. In this study, 10 patients were selected, based on frequency matching for sex, 5-year age interval, and index year, for each patient with RA to form a comparison cohort. In the comparison cohort, those ages less than 20 years, more than 80 years on the index date, or with a diagnosis of primary Sjögren’s syndrome, defined by the catastrophic illness datafile, were excluded from the study.

A number of diseases were identified as potential confounders, including hypertension, diabetes mellitus, congestive heart failure, chronic pulmonary disease, malignancy, dyslipidemia, coronary artery disease, myocardial infraction, peripheral vascular disease, cerebrovascular disease, dementia, musculoskeletal disorders, peptic ulcer disease, chronic kidney disease, and liver disease. These diseases were identified by their respective ICD-9-CM codes and inclusion criteria as in our previous study [12].

Identification of dental disorders

The RA cohort and the comparison cohort were followed until our outcome of interest had occurred or when the end of the follow-up period had reached. Only dental visits occurred at least 90 days after the index date were included in the analysis. Various dental disorders of patients with RA were reviewed according to ICD-9-CM codes. We selected common or potentially RA-related dental disorders based on the frequency of dental visits and they included: (1) periodontitis (ICD-9 codes: 523.3, 523.4, 523.5, and 523.8) (2) dental caries (ICD-9 code: 521.0), (3) gingivitis (ICD-9 codes: 523.0, 523.1, and 523.2), (4) pulpitis (ICD-9 code: 522.0), (5) oral ulceration (ICD-9 code: 528.2), (6) stomatitis (ICD-9 code: 528.0), and (7) temporomandibular joint disorders (ICD-9 code: 524.6). The incidence and IRRs for each of these dental disorders were separately calculated in the RA cohort and the comparison cohort. The follow-up duration used for the calculation of person-years was obtained by subtracting the date when the outcome of interest occurred from the index date. Patients who were diagnosed with the outcome of interest within 90 days before the index date were excluded from the calculation of the incidence and IRRs.

Statistical analysis

Demographic data, the prevalence and frequency of the visits due to specific dental disorders between the RA cohort and the comparison cohort were compared using the Chi-square test, the t-test, or the non-parametric Mann–Whitney U-test, as appropriate. The incidence per 1000 person-years was calculated separately for the RA cohort and the comparison cohort. Poisson regression models using person-years as the offset variable, with or without adjusting for potential confounding variables were used to calculate IRRs for the outcome variables. All analyses were conducted with IBM SPSS Statistics for Windows, version 24.0 (IBM Corp, Armonk, NY, USA). A p-value less than 0.05 was considered statistically significant.

Results

Basic characteristics and comorbidities of patients in the RA cohort and in the comparison cohort

We selected 1337 newly-diagnosed patients with RA and 13,370 patients without RA in this study. There were no significant differences in sex, age, and geographic region between the two cohorts. In Table 1, the insurance premium levels were significantly higher in the RA cohort. Patients with RA showed a significantly higher proportion of chronic pulmonary diseases (3.0% vs. 2.0%; p = 0.019), musculoskeletal disorders (4.5% vs. 0.4%; p < 0.001), and peptic ulcer diseases (5.1% vs. 2.5%; p < 0.001), but a significantly lower proportion of cancer (1.0% vs. 1.8%; p = 0.033) compared with those in the comparison cohort.

Table 1.

Basic characteristics of the rheumatoid arthritis cohort and the comparison cohort (N = 14,707)

Variable N (%) p value
Rheumatoid arthritis cohort
1337 (9.1)
Comparison cohort
13,370 (90.9)
Sex  > 0.999
 Male 302 (22.6) 3020 (22.6)
 Female 1035 (77.4) 10,350 (77.4)
Age interval at entry (years)  > 0.999
 20–54 721 (53.9) 7210 (53.9)
 > 55 616 (46.1) 6160 (46.1)
Mean age (standard deviation), years 53.2 (13.4) 53.2 (13.4)  > 0.999
Median (lower and upper quartile), years 53.0 (44.0, 63.0) 53.0 (44.0, 63.0)
Salary grades for insurance (n = 14,689)  < 0.001
 ≤ 19,000 611 (46.0) 7203 (53.9)
 19,001–24,000 483 (36.4) 4115 (30.8)
 ≥ 24,001 234 (17.6) 2043 (15.3)
Geographic region (n = 14,241) 0.254
 Northern 748 (58.1) 7880 (60.8)
 Central 234 (18.2) 2140 (16.5)
 Southern 278 (21.6) 2653 (20.5)
 Eastern 28 (2.2) 280 (2.2)
Comorbidities
 Hypertension 106 (7.9) 1022 (7.6) 0.710
 Diabetes 52 (3.9) 580 (4.3) 0.440
 Congestive heart failure 8 (0.6) 62 (0.5) 0.495
 Chronic pulmonary disease 40 (3.0) 271 (2.0) 0.019
 Cancer 13 (1.0) 235 (1.8) 0.033
 Dyslipidemia 40 (3.0) 327 (2.4) 0.222
 Coronary artery disease 3 (0.2) 46 (0.3) 0.469
 Prior myocardial infarction 1 (0.1) 10 (0.1)  > 0.999
 Peripheral vascular disease 1 (0.1) 18 (0.1) 0.561
 Cerebrovascular disease 25 (1.9) 230 (1.7) 0.689
 Dementia 1 (0.1) 35 (0.3) 0.187
 Musculoskeletal disordersa 60 (4.5) 50 (0.4)  < 0.001
 Peptic ulcer disease 68 (5.1) 337 (2.5)  < 0.001
 Chronic kidney disease 16 (1.2) 114 (0.9) 0.200
 Liver disease 22 (1.6) 174 (1.3) 0.296

Socioeconomic status was estimated by insurance premiums based on salary. Low: < 19,000 New Taiwan dollars (NT$); middle: 19,001–24,000; and high: > 24,000

P values were obtained by Chi-square test for categorical variables and t-test or Mann–Whitney U-test for continuous variables, as appropriate

aExcluding the diagnosis of rheumatoid arthritis (ICD-9 code: 714.0)

Prevalence, frequency, and common causes of dental visits

Table 2 showed that patients with RA had a higher prevalence (70.3% vs. 66.7%, p = 0.008) and frequency (medium 2.67 vs. 1.78 per year, p < 0.001) of dental visits compared with those without RA. The prevalence and frequency of dental visits for dental caries, pulpitis, gingivitis, periodontitis, and oral ulceration, but not stomatitis were found to be significantly higher in the RA cohort. Moreover, the prevalence and frequency of dental visits for temporomandibular joint disorders were slightly higher in the RA cohort with marginal significance (1.6% vs. 1.0%, p = 0.065).

Table 2.

The prevalence and frequency of dental disorders in the rheumatoid arthritis and comparison cohort (N = 14,707)

Variable N (%) p value
Rheumatoid arthritis cohort
1337 (9.1)
Comparison cohort
13,370 (90.9)
Dental visits
 Prevalence (%) 940 (70.3) 8921 (66.7) 0.008
 Number of visits, median (Q1, Q3) (per year) 2.67 (0.0, 14.2) 1.78 (0.0, 10.9)  < 0.001
 Number of visits, mean (SD) (per year) 14.25 (28.87) 11.79 (26.56)
Dental caries (ICD-9-CM 521.0)
 Prevalence (%) 747 (55.9) 6885 (51.5) 0.002
 Number of visits, median (Q1, Q3) (per year) 0.55 (0.0, 4.6) 0.20 (0.0, 3.4)  < 0.001
 Number of visits, mean (SD) (per year) 4.76 (9.89) 4.07 (9.67)
Pulpitis (ICD-9-CM 522.0)
 Prevalence (%) 421 (31.5) 3755 (28.1) 0.009
 Number of visits, median (Q1, Q3) (per year) 0.00 (0.0, 0.8) 0.00 (0.0, 0.4) 0.002
 Number of visits, mean (SD) (per year) 1.45 (4.15) 1.17 (3.61)
Gingivitis (ICD-9-CM 523.0, 523.1, 523.2)
 Prevalence (%) 449 (33.6) 4005 (30.0) 0.006
 Number of visits, median (Q1, Q3) (per year) 0.00 (0.0, 0.9) 0.00 (0.0, 0.5) 0.001
 Number of visits, mean (SD) (per year) 1.45 (4.32) 1.11 (3.64)
Periodontitis (ICD-9-CM 523.3, 523.4, 523.5, 523.8)
 Prevalence (%) 762 (57.0) 7172 (53.6) 0.019
 Number of visits, median (Q1, Q3) (per year) 0.59 (0.0, 3.7) 0.28 (0.0, 3.1) 0.001
 Number of visits, mean (SD) (per year) 4.46 (10.53) 3.85 (9.91)
Oral ulceration (ICD-9-CM 528.2)
 Prevalence (%) 229 (17.1) 1775 (13.3)  < 0.001
 Number of visits, median (Q1, Q3) (per year) 0.00 (0.0, 0.0) 0.00 (0.0, 0.0)  < 0.001
 Number of visits, mean (SD) (per year) 0.80 (4.40) 0.52 (2.83)
Stomatitis (ICD-9-CM 528.0)
 Prevalence (%) 124 (9.3) 1108 (8.3) 0.214
 Number of visits, median (Q1, Q3) (per year) 0.00 (0.0, 0.0) 0.00 (0.0, 0.0) 0.197
 Number of visits, mean (SD) (per year) 0.39 (2.01) 0.31 (2.41)
Temporomandibular joint disorders (ICD-9-CM 524.6)
 Prevalence (%) 21 (1.6) 137 (1.0) 0.065
 Number of visits, median (Q1, Q3) (per year) 0.00 (0.0, 0.0) 0.00 (0.0, 0.0) 0.065
 Number of visits, mean (SD) (per year) 0.04 (0.46) 0.03 (0.46)

P values were obtained by Chi-square test for comparison of prevalence and Mann–Whitney U-test for comparison of medians of number of visits

ICD-9-CM, International Classification of Diseases, Ninth revision, clinical modification; Q1, lower quartile; Q3, upper quartile; SD, standard deviation

Incidence of visits for dental caries and pulpitis in patients with RA

In Table 3, we found that patients with RA had an increased incidence of visits for dental caries (adjusted IRR = 1.16, 95% CI 1.07–1.26, p < 0.001) compared with patients without RA. When stratified by sex, female RA patients had an elevated incidence for dental caries (adjusted IRR = 1.21, 95% CI 1.11–1.33, p < 0.001), but not in male RA patients (adjusted IRR = 0.98, 95% CI 0.81–1.18, p = 0.804). Moreover, compared with patients without RA, those with RA, both the 20–55 years age group (adjusted IRR = 1.18, CI 1.06–1.31; p = 0.002) and > 55 years age group (adjusted IRR = 1.18, CI 1.03–1.34, p = 0.014) showed an increased incidence of dental caries.

Table 3.

Incidence and incidence rate ratios of visits for dental caries and pulpitis in the rheumatoid arthritis cohort and the comparison cohort

Disorder Group Rheumatoid arthritis cohort Comparison cohort IRR (95% CI) aIRR (95% CI)
(ICD-9-CM) (Years) No. of patient Person-years Incidence No. of patient Person-years Incidence p value p value

Dental cariesa

(521.0)

Overall 683 4009 170.37 6085 41,693 145.95

1.17 (1.08–1.26)

 < 0.001

1.16 (1.07–1.26)

 < 0.001

Sex
 Male 125 1019 122.67 1275 9768 130.53

0.94 (0.78–1.13)

0.508

0.98 (0.81–1.18)

0.804

 Female 558 2990 186.62 4810 31,925 150.67

1.24 (1.14–1.35)

 < 0.001

1.21 (1.11–1.33)

 < 0.001

Age group (years)
 20–54 414 2112 196.02 3736 22,448 166.43

1.18 (1.06–1.30)

0.002

1.18 (1.06–1.31)

0.002

 > 55 269 1897 141.80 2349 19,245 122.06

1.16 (1.02–1.32)

0.020

1.18 (1.03–1.34)

0.014

Pulpitisb

(522.0)

Overall 405 5885 68.82 3608 58,912 61.24

1.12 (1.01–1.24)

0.026

1.12 (1.00–1.24)

0.044

Sex
 Male 65 1386 46.90 738 13,553 54.45

0.86 (0.67–1.11)

0.249

0.89 (0.68–1.15)

0.368

 Female 340 4499 75.57 2870 45,359 63.27

1.19 (1.07–1.34)

0.002

1.18 (1.05–1.32)

0.006

Age group (years)
 20–54 242 3291 73.53 2207 33,505 65.87

1.12 (0.98–1.28)

0.104

1.11 (0.96–1.27)

0.157

 > 55 163 2594 62.84 1401 25,407 55.14

1.14 (0.97–1.34)

0.115

1.15 (0.97–1.36)

0.105

Adjusted for age, sex, socioeconomic status, geographic region, hypertension, diabetes, congestive heart failure, chronic pulmonary disease, cancer, dyslipidemia, coronary artery disease, prior myocardial infarction, peripheral vascular disease, cerebrovascular disease, dementia, musculoskeletal disorders, peptic ulcer disease, chronic kidney disease, and liver disease

aIRR, adjusted incidence rate ratio; ICD-9-CM, International Classification of Diseases, Ninth revision, clinical modification; IRR, incidence rate ratio

aPatients who were diagnosed with dental caries within 90 days before the index date were excluded and 1248 patients with rheumatoid arthritis and 12,332 controls were included in the analysis

bPatients who were diagnosed with pulpitis within 90 days before the index date were excluded and 1307 patients with rheumatoid arthritis and 13,061 controls were included in the analysis

Patients with RA also showed an elevated incidence of visits for pulpitis (adjusted IRR = 1.12, 95% CI 1.00–1.24, p = 0.044) compared with those without RA. Female patients with RA had an elevated incidence for pulpitis (adjusted IRR = 1.18, 95% CI 1.05–1.32, p = 0.006), but not in male patients (adjusted IRR = 0.89, 95% CI 0.68–1.15, p = 0.368). The incidence for pulpitis in patients with RA was not significantly higher in different age groups.

Incidence of visits for gingivitis and periodontitis in patients with RA

In Table 4, we found that patients with RA had a significantly higher incidence of visits for gingivitis compared to those without RA (adjusted IRR = 1.13, 95% CI 1.01–1.25, p = 0.027). Female patients with RA showed an increased visits for gingivitis (adjusted IRR = 1.19, 95% CI 1.06–1.34, p = 0.003), but male patients did not (adjusted IRR = 0.86, 95% CI 0.66–1.11, p = 0.241). When stratified by age group, RA patients in the younger age group (20–55 years) had an increased incidence of gingivitis (adjusted IRR = 1.17, 95% CI 1.02–1.33, p = 0.022), but not in the older age group (aged > 55 years; adjusted IRR = 1.09, 95% CI 0.92–1.33, p = 0.330).

Table 4.

Incidence and incidence rate ratios of visits for gingivitis and periodontitis in the rheumatoid arthritis cohort and the comparison cohort

Disorder Age group Rheumatoid arthritis cohort Comparison cohort IRR (95% CI) aIRR (95% CI)
(ICD-9-CM) (Years) No. of patient Person-years Incidence No. of patient Person-years Incidence p value p value
Gingivitisa (523.0, 523.1, 523.2)
Overall 419 5938 70.56 3805 60,310 63.09

1.12 (1.01–1.24)

0.030

1.13 (1.01–1.25)

0.027

Sex
 Male 67 1357 49.37 817 13,499 60.52

0.82 (0.64–1.05)

0.109

0.86 (0.66–1.11)

0.241

 Female 352 4581 76.84 2988 46,811 63.83

1.20 (1.08–1.34)

0.001

1.19 (1.06–1.34)

0.003

Age group (years)
 20–54 269 3258 82.57 2443 33,870 72.13

1.14 (1.01–1.30)

0.036

1.17 (1.02–1.33)

0.022

 > 55 150 2680 55.97 1362 26,440 51.51

1.09 (0.92–1.29)

0.334

1.09 (0.92–1.30)

0.330

Periodontitisb

(523.3, 523.4, 523.5, 523.8)

Overall 694 4049 171.40 6239 40,686 153.35

1.12 (1.03–1.21)

0.005

1.13 (1.04–1.22)

0.004

Sex
 Male 144 989 145.60 1381 8943 154.42

0.94 (0.79–1.12)

0.503

1.00 (0.83–1.19)

0.962

 Female 550 3060 179.74 4858 31,743 153.04

1.17 (1.08–1.28)

 < 0.001

1.17 (1.07–1.28)

0.001

Age group (years)
 20–54 405 2207 183.51 3722 22,673 164.16

1.12 (1.01–1.24)

0.033

1.15 (1.03–1.28)

0.013

 > 55 289 1842 156.89 2517 18,013 139.73

1.12 (0.99–1.27)

0.063

1.14 (1.00–1.29)

0.043

Adjusted for age, sex, socioeconomic status, geographic region, hypertension, diabetes, congestive heart failure, chronic pulmonary disease, cancer, dyslipidemia, coronary artery disease, prior myocardial infarction, peripheral vascular disease, cerebrovascular disease, dementia, musculoskeletal disorders, peptic ulcer disease, chronic kidney disease, and liver disease

aIRR, adjusted incidence rate ratio; ICD-9-CM, International Classification of Diseases, Ninth revision, clinical modification; IRR, incidence rate ratio

aPatients who were diagnosed with gingivitis within 90 days before the index date were excluded and 1288 patients with rheumatoid arthritis and 13,019 controls were included in the analysis

bPatients who were diagnosed with periodontitis within 90 days before the index date were excluded and 1248 patients with rheumatoid arthritis and 12,152 controls were included in the analysis

Patients with RA had an elevated incidence of visit for periodontitis compared with patients without RA (adjusted IRR = 1.13, 95% CI 1.04–1.22, p = 0.004). Moreover, female patients with RA showed a significantly increased incidence of periodontitis (adjusted IRR = 1.17, 95% CI 1.07–1.28, p = 0.001), but not in male patients with RA (adjusted IRR = 1.00, 95% CI 0.83–1.19, p = 0.962). Moreover, patients with RA showed an increased incidence of periodontitis in the 20–54 years group (adjusted IRR = 1.15, 95% CI 1.03–1.28, p = 0.013) and the > 55 years group (adjusted IRR = 1.14, 95% CI 1.00–1.29, p = 0.043).

Incidence of visits for oral ulceration and temporomandibular joint disorder in patients with RA

In Table 5, we found that patients with RA had an elevated incidence of oral ulceration compared with patients without RA (adjusted IRR = 1.24, 95% CI 1.08–1.44, p = 0.003). Female RA patients with RA showed an elevated incidence for having oral ulceration (adjusted IRR = 1.29, 95% CI 1.10–1.51, p = 0.002), but not in male patients with RA (adjusted IRR = 1.05, 95% CI 0.73–1.50, p = 0.804). When stratified by age, the younger group patients with RA showed an elevated incidence of oral ulceration (adjusted IRR = 1.30, 95% CI 1.06–1.58, p = 0.011), but not those with older age group (adjusted IRR = 1.21, CI 0.98–1.50, p = 0.083).

Table 5.

Incidence and incidence rate ratios of visits for oral ulceration and temporomandibular joint disorders in the rheumatoid arthritis cohort and the comparison cohort

Disorder Age group (years) Rheumatoid arthritis cohort Comparison cohort IRR (95% CI) aIRR (95% CI)
(ICD-9-CM) No. of patient Person-years Incidence No. of patient Person-years Incidence p value P value
Oral ulcerationa (528.2)
Overall 222 7057 31.46 1734 70,434 24.62

1.28 (1.11–1.47)

0.001

1.24 (1.08–1.44)0.003
Sex
 Male 34 1539 22.09 351 15,880 22.10

1.00 (0.70–1.42)

0.999

1.05 (0.73–1.50)

0.804

 Female 188 5518 34.07 1383 54,554 25.35

1.34 (1.15–1.56)

< 0.001

1.29 (1.10–1.51)

0.002

Age group (years)
 20–54 121 4117 29.39 934 41,241 22.65

1.30 (1.07–1.57)

0.007

1.30 (1.06–1.58)

0.011

 > 55 101 2940 34.35 800 29,193 27.40

1.25 (1.02–1.54)

0.032

1.21 (0.98–1.50)

0.083

Temporomandibular joint disordersb (524.6)
Overall 18 7697 2.34 117 76,580 1.53

1.53 (0.93–2.51)

0.093

1.31 (0.77–2.23)

0.320

Sex
 Male 2 1660 1.20 23 17,083 1.35

0.90 (0.21–3.80)

0.881

0.79 (0.18–3.42)

0.750

 Female 16 6037 2.65 94 59,497 1.58

1.68 (0.99–2.85)

0.056

1.33 (0.75–2.36)

0.327

Age group (years)
 20–54 11 4448 2.47 70 44,502 1.57

1.57 (0.83–2.97)

0.163

1.40 (0.72–2.76)

0.323

 > 55 7 3249 2.15 47 32,078 1.47

1.47 (0.66–3.25)

0.341

1.24 (0.52–2.96)

0.630

Adjusted for age, sex, socioeconomic status, geographic region, hypertension, diabetes, congestive heart failure, chronic pulmonary disease, cancer, dyslipidemia, coronary artery disease, prior myocardial infarction, peripheral vascular disease, cerebrovascular disease, dementia, musculoskeletal disorders, peptic ulcer disease, chronic kidney disease, and liver disease

aIRR, adjusted incidence rate ratio; ICD-9-CM, International Classification of Diseases, Ninth revision, clinical modification; IRR, incidence rate ratio

aPatients who were diagnosed with oral ulceration within 90 days before the index date were excluded and 1326 patients with rheumatoid arthritis and 13,275 controls were included in the analysis

bPatients who were diagnosed with temporomandibular joint disorders within 90 days before the index date were excluded and 1302 patients with rheumatoid arthritis and 13,229 controls were included in the analysis

Furthermore, no significant differences were observed in developing temporomandibular joint disorders between patients with and without RA either in the overall analysis (adjusted IRR = 1.31, 95% CI 0.77–2.23, p = 0.320) or in the subgroup analyses stratified by sex or age group.

Discussion

In this secondary cohort study, we found the prevalence and frequency of dental visits were increased in patients with RA. The incidence of visits for dental caries, pulpitis, gingivitis, periodontitis and oral ulcer, but not temporomandibular joint disorders was significantly higher in patients with RA especially female patients. For age group, the risks of dental caries and periodontitis were increased in both the younger and older age groups and the risk of gingivitis and oral ulcer were increased in younger age group.

Dental caries is a biofilm-mediated disease with multiple contributing factors that drives net localized demineralization of the teeth [14]. Although RA is considered a risk factor for dental caries, few studies have shown that the frequency and severity of dental caries were also higher in patients with RA [9, 15]. It is interesting to note that RA disease activity could be associated with the severity of dental caries [15]. It should be noted that primary Sjögren's syndrome is a strong risk factor for developing dental caries (aIRR = 1.64) according to our previous study [12]. Therefore, patients with a diagnosis of primary Sjögren's syndrome were excluded from this study. However, patients with RA might still have secondary Sjögren's syndrome. Therefore, it is possible that the developing of dental caries and pulpitis were mediated through hyposalivation in patients with RA [16].

There is a very close and complex relationship between periodontitis and RA. Both periodontitis and RA shared similar pathogenesis, including imbalance between pro- and anti-inflammatory cytokines, the role of smoking, microbial dysbiosis especially Porphyromonas gingivalis, and genetic background [17]. Therefore, our finding was as expected. Periodontitis, a major inflammatory disease of the oral mucosa, is epidemiologically associated with other chronic inflammation-driven disorders, including cardiometabolic, neurodegenerative and autoimmune diseases, and cancer [18]. A recent systematic review analysis of eight articles on nonsurgical treatment of patients with periodontitis found that periodontitis treatment could improve clinical and laboratory test parameters, such as disease activity score by 28 joints [DAS28] and erythrocyte sedimentation rate, of RA [19]. The causal relationship of periodontitis and RA remained to be elucidated. The incidence for oral ulceration was increased in patients with RA, and it could be related to the side effect of common medication methotrexate in the treatment of RA [20]. It is known that RA could destruct the temporomandibular joint [21]. Byun et al. reported a 2.52-fold increased risk of developing temporomandibular joint disorder in patients with RA in a cohort study of 3122 patients with RA and 12,488 matched controls [22]. The sample size of patients with RA was 1337 in the present study, and this smaller sample size might explain why only a trend of increased risk of developing temporomandibular joint disorder was observed in patients with RA.

Overall the findings of this secondary cohort study indicated that patients with had a poor oral health condition, which is similar to a Korean study [23]. Poor oral health might increase personal medical expenses and burden of health insurance. In contrast, good oral health might be a starting point for the general health and well-being of our body [24]. Rheumatologists should be vigilant for the dental condition in their patients with RA [25] and dental professionals should be aware for the potential poor oral health in patients with RA and effect should be made to enhance their oral health.

The strengths of this study is the large number of patients with RA (n = 1337) and a 12-year follow up period. All the diagnoses were made by specialists and the study sample was representative for the whole population in Taiwan. Nevertheless, there are some limitations. First, identification of dental disorders was based on the claim data, some patients with only mild dental disorders might not visit dental professionals. Second, due to the limitation of claim data, we did not have information on the severity of RA and dental disorders. Third, the database used in this study spanned from January 2000 to December 2012, whether the current situation remained the same will require confirmation.

In conclusion, we found an elevated prevalence and frequency of dental visits in patients with RA. In addition, elevated incidence of visits for dental disorders, including dental caries, pulpitis, gingivitis, periodontitis, and oral ulceration, were observed. Both the rheumatologist and dental professionals should accessed the oral health condition regularly in patients with RA.

Acknowledgements

This study is based in part on data from the National Health Insurance Research Database provided by the National Health Insurance Administration, Ministry of Health and Welfare and managed by the National Health Research Institutes, Taiwan. The interpretation and conclusions contained herein do not represent those of the National Health Insurance Administration, Ministry of Health and Welfare or the National Health Research Institutes, Taiwan.

Author contributions

C-YJ, C-WH and M-CL conceived and designed this study. C-YJ, C-WH and M-CL contributed to the data collection and interpretation; C-WH and M-CL contributed to the data analysis; C-YJ, C-WH and M-CL wrote the manuscript. All authors critically reviewed and approved the final version of the manuscript.

Funding

This work was supported by Grants from Buddhist Tzu Chi Medical Foundation, Taiwan (No: TCMF-A 108-05). The funding body had no role in the design of the study, collection, analysis and interpretation of data or in the writing of the manuscript.

Availability of data and materials

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to the Taiwan Personal Information Protection Act.

Declarations

Ethics approval and consent to participate

The study protocol was approved by the institutional review board of Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation (No. B10004021). The study was performed in accordance with the Declaration of Helsinki. The need for informed consent from individuals was waived by the institutional review board of Dalin Tzu Chi Hospital because the all the personal data in NHIRD were deidentified.

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Footnotes

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

References

  • 1.Kapila YL. Oral health's inextricable connection to systemic health: Special populations bring to bear multimodal relationships and factors connecting periodontal disease to systemic diseases and conditions. Periodontol. 2000;2021(87):11–16. doi: 10.1111/prd.12398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Scott DL, Wolfe F, Huizinga TW. Rheumatoid arthritis. Lancet. 2010;376:1094–1108. doi: 10.1016/S0140-6736(10)60826-4. [DOI] [PubMed] [Google Scholar]
  • 3.Chou CT, Pei L, Chang DM, Lee CF, Schumacher HR, Liang MH. Prevalence of rheumatic diseases in Taiwan: a population study of urban, suburban, rural differences. J Rheumatol. 1994;21:302–306. [PubMed] [Google Scholar]
  • 4.Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016;388:2023–2038. doi: 10.1016/S0140-6736(16)30173-8. [DOI] [PubMed] [Google Scholar]
  • 5.Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun Rev. 2021;20:102776. doi: 10.1016/j.autrev.2021.102776. [DOI] [PubMed] [Google Scholar]
  • 6.de Souza S, Bansal RK, Galloway J. Rheumatoid arthritis - an update for general dental practitioners. Br Dent J. 2016;221:667–673. doi: 10.1038/sj.bdj.2016.866. [DOI] [PubMed] [Google Scholar]
  • 7.Chen HH, Huang N, Chen YM, Chen TJ, Chou P, Lee YL, et al. Association between a history of periodontitis and the risk of rheumatoid arthritis: a nationwide, population-based, case-control study. Ann Rheum Dis. 2013;72:1206–1211. doi: 10.1136/annrheumdis-2012-201593. [DOI] [PubMed] [Google Scholar]
  • 8.Tang Q, Fu H, Qin B, Hu Z, Liu Y, Liang Y, et al. A possible link between rheumatoid arthritis and periodontitis: a systematic review and meta-analysis. Int J Periodontics Restorative Dent. 2017;37:79–86. doi: 10.11607/prd.2656. [DOI] [PubMed] [Google Scholar]
  • 9.Martinez-Martinez RE, Domínguez-Pérez RA, Sancho-Mata J, Abud-Mendoza C, Ayala-Herrera JL, Popoca-Hernandez EA. The frequency and severity of dental caries, and counts of cariogenic bacteria in rheumatoid arthritis patients. Dent Med Probl. 2019;56:137–142. doi: 10.17219/dmp/105340. [DOI] [PubMed] [Google Scholar]
  • 10.Lin CY, Chung CH, Chu HY, Chen LC, Tu KH, Tsao CH, et al. Prevalence of temporomandibular disorders in rheumatoid arthritis and associated risk factors: a nationwide study in Taiwan. J Oral Facial Pain Headache. 2017;31:e29–e36. doi: 10.11607/ofph.1917. [DOI] [PubMed] [Google Scholar]
  • 11.Kroese JM, Volgenant CMC, Crielaard W, Loos B, van Schaardenburg D, Visscher CM, et al. Temporomandibular disorders in patients with early rheumatoid arthritis and at-risk individuals in the Dutch population: a cross-sectional study. RMD Open. 2021;7:e001485. doi: 10.1136/rmdopen-2020-001485. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Chuang CJ, Hsu CW, Lu MC, Koo M. Increased risk of developing dental diseases in patients with primary Sjögren's syndrome-A secondary cohort analysis of population-based claims data. PLoS ONE. 2020;15:e0239442. doi: 10.1371/journal.pone.0239442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–324. doi: 10.1002/art.1780310302. [DOI] [PubMed] [Google Scholar]
  • 14.Sabharwal A, Stellrecht E, Scannapieco FA. Associations between dental caries and systemic diseases: a scoping review. BMC Oral Health. 2021;21:472. doi: 10.1186/s12903-021-01803-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Äyräväinen L, Heikkinen AM, Kuuliala A, Ahola K, Koivuniemi R, Peltola J, et al. Activity of rheumatoid arthritis correlates with oral inflammatory burden. Rheumatol Int. 2018;38:1661–1669. doi: 10.1007/s00296-018-4108-z. [DOI] [PubMed] [Google Scholar]
  • 16.Pedersen AML, Sørensen CE, Proctor GB, Carpenter GH, Ekström J. Salivary secretion in health and disease. J Oral Rehabil. 2018;45:730–746. doi: 10.1111/joor.12664. [DOI] [PubMed] [Google Scholar]
  • 17.de Molon RS, Rossa C, Jr, Thurlings RM, Cirelli JA, Koenders MI. Linkage of periodontitis and rheumatoid arthritis: current evidence and potential biological interactions. Int J Mol Sci. 2019;20:4541. doi: 10.3390/ijms20184541. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Hajishengallis G, Chavakis T. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities. Nat Rev Immunol. 2021;21:426–440. doi: 10.1038/s41577-020-00488-6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Silvestre FJ, Silvestre-Rangil J, Bagán L, Bagán JV. Effect of nonsurgical periodontal treatment in patients with periodontitis and rheumatoid arthritis: a systematic review. Med Oral Patol Oral Cir Bucal. 2016;21:e349–e354. doi: 10.4317/medoral.20974. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Nakarmi S, Pudasaini K, Adhikari B, Vaidya B. Adverse events profile of low-dose methotrexate in nepalese patients with rheumatoid arthritis: an observational study. J Nepal Health Res Counc. 2020;18:360–365. doi: 10.33314/jnhrc.v18i3.2743. [DOI] [PubMed] [Google Scholar]
  • 21.Campos DES, de Araújo Ferreira-Muniz I, de Souza Villarim NL, Ribeiro ILA, Batista AUD, Bonan PRF, et al. Is there an association between rheumatoid arthritis and bone changes in the temporomandibular joint diagnosed by cone-beam computed tomography? A systematic review and meta-analysis. Clin Oral Investig. 2021;25:2449–59. doi: 10.1007/s00784-021-03817-8. [DOI] [PubMed] [Google Scholar]
  • 22.Byun SH, Min C, Choi HG, Hong SJ. Increased risk of temporomandibular joint disorder in patients with rheumatoid arthritis: A longitudinal follow-up study. J Clin Med. 2020;9:3005. doi: 10.3390/jcm9093005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Shim H, Koo J, Ahn J. Association between rheumatoid arthritis and poor self-perceived oral health in Korean adults. Healthcare (Basel) 2022;10:427. doi: 10.3390/healthcare10030427. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Fiorillo L. Oral health: the first step to well-being. Medicina (Kaunas) 2019;55:676. doi: 10.3390/medicina55100676. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Treister N, Glick M. Rheumatoid arthritis: a review and suggested dental care considerations. J Am Dent Assoc. 1999;130:689–698. doi: 10.14219/jada.archive.1999.0279. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Data Availability Statement

The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to the Taiwan Personal Information Protection Act.


Articles from BMC Oral Health are provided here courtesy of BMC

RESOURCES